The Victor Phillip Dahdaleh Heart and Lung Research Institute Cambridge

A joint venture between the University of Cambridge and Royal Papworth Hospital NHS Foundation Trust, the Victor Phillip Dahdaleh Heart and Lung Research Institute (HLRI) is a major facility accommodating Europe’s largest concentration of heart and lung medicine scientists and clinicians. It draws together the NHS and academia to create a world-leading research environment and is a unique facility of its kind in the UK.

Hundreds of staff are now housed under one roof, tackling cardiovascular and respiratory diseases. The impressive complex is home to cutting-edge laboratories in genomics, population sciences and research into cellular mechanisms of disease and translational science. There’s also a 10-bed Clinical Research Facility for patient studies of new treatments, and spaces for education and training/ seminar purposes.

Sector Healthcare
Location Cambridge
Architect R H Partnership Architects
Fabricator JPJ Installations Ltd
Contractor SDC

Prestigious Appearance

Creating the largest Biotech cluster outside of the United States meant that the specification, already approved on previous projects, had to be met. Novastruct systems were selected for this important building by the University of Cambridge.

Installed by approved specialist subcontractor JPJ Installations Ltd, Novastruct’s FSX 100 Zone Drained and FSX 100 Structurally Silicone Glazed (SSG) Curtain Wall systems, and WSX 720 Windows, feature on the main elevations. In high access areas, the DSX 190 TB Welded Door is used and on the ground floor.

The prestigious façade appearance is enhanced by the Novastruct curtain walling that was installed in a purpose-designed “punch through” configuration with the metal cladding, in combination with opaque lookalike glazed panels, decorated louvres and spandrel panels that were also included as part of the design. Two full height curtain wall elements linking the East and West blocks complete the building.

Award Winner

HLRI was officially opened by Her Royal Highness The Duchess of Gloucester and is now bringing together the NHS, academics, industry and charity to provide a leading-edge environment to help tackle cardiovascular and respiratory diseases that are among the biggest causes of death worldwide.

Intended to maximise interdisciplinary science, the Institute is now firmly embarked on its ambitious fiveyear goal of demonstrating proof-of-concept for a minimum of ten new drugs or diagnostic approaches to combat conditions such as heart attacks, pulmonary hypertension, lung cancers, cystic fibrosis and acute respiratory distress syndrome.

The building’s attractive, distinctive and purposeful design has now won the Best New Building Over £2m category in the Greater Cambridge Design & Construction Awards.